167 related articles for article (PubMed ID: 9121766)
1. MyoD prevents cyclinA/cdk2 containing E2F complexes formation in terminally differentiated myocytes.
Puri PL; Balsano C; Burgio VL; Chirillo P; Natoli G; Ricci L; Mattei E; Graessmann A; Levrero M
Oncogene; 1997 Mar; 14(10):1171-84. PubMed ID: 9121766
[TBL] [Abstract][Full Text] [Related]
2. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
3. E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes.
Timchenko NA; Wilde M; Iakova P; Albrecht JH; Darlington GJ
Nucleic Acids Res; 1999 Sep; 27(17):3621-30. PubMed ID: 10446255
[TBL] [Abstract][Full Text] [Related]
4. p21 Disrupts the interaction between cdk2 and the E2F-p130 complex.
Shiyanov P; Bagchi S; Adami G; Kokontis J; Hay N; Arroyo M; Morozov A; Raychaudhuri P
Mol Cell Biol; 1996 Mar; 16(3):737-44. PubMed ID: 8622674
[TBL] [Abstract][Full Text] [Related]
5. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
6. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
Afshari CA; Nichols MA; Xiong Y; Mudryj M
Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
[TBL] [Abstract][Full Text] [Related]
7. Changes in E2F complexes containing retinoblastoma protein family members and increased cyclin-dependent kinase inhibitor activities during terminal differentiation of cardiomyocytes.
Flink IL; Oana S; Maitra N; Bahl JJ; Morkin E
J Mol Cell Cardiol; 1998 Mar; 30(3):563-78. PubMed ID: 9515032
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling of p21 induction and MyoD activation results in the failure of irreversible cell cycle arrest in doxorubicin-treated myocytes.
Puri PL; Medaglia S; Cimino L; Maselli C; Germani A; De Marzio E; Levrero M; Balsano C
J Cell Biochem; 1997 Jul; 66(1):27-36. PubMed ID: 9215525
[TBL] [Abstract][Full Text] [Related]
9. Deregulation of specific E2F complexes by the v-mos oncogene.
Afshari CA; Rhodes N; Paules RS; Mudryj M
Oncogene; 1997 Jun; 14(25):3029-38. PubMed ID: 9223666
[TBL] [Abstract][Full Text] [Related]
10. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity.
Woo MS; Sánchez I; Dynlacht BD
Mol Cell Biol; 1997 Jul; 17(7):3566-79. PubMed ID: 9199292
[TBL] [Abstract][Full Text] [Related]
11. A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence.
Carroll JS; Prall OW; Musgrove EA; Sutherland RL
J Biol Chem; 2000 Dec; 275(49):38221-9. PubMed ID: 10991938
[TBL] [Abstract][Full Text] [Related]
12. Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.
Lees E; Faha B; Dulic V; Reed SI; Harlow E
Genes Dev; 1992 Oct; 6(10):1874-85. PubMed ID: 1398067
[TBL] [Abstract][Full Text] [Related]
13. Expression of E1A in terminally differentiated muscle cells reactivates the cell cycle and suppresses tissue-specific genes by separable mechanisms.
Tiainen M; Spitkovsky D; Jansen-Dürr P; Sacchi A; Crescenzi M
Mol Cell Biol; 1996 Oct; 16(10):5302-12. PubMed ID: 8816442
[TBL] [Abstract][Full Text] [Related]
14. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
Xu M; Sheppard KA; Peng CY; Yee AS; Piwnica-Worms H
Mol Cell Biol; 1994 Dec; 14(12):8420-31. PubMed ID: 7969176
[TBL] [Abstract][Full Text] [Related]
15. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle-specific association of E2F with the p130 E1A-binding protein.
Cobrinik D; Whyte P; Peeper DS; Jacks T; Weinberg RA
Genes Dev; 1993 Dec; 7(12A):2392-404. PubMed ID: 8253385
[TBL] [Abstract][Full Text] [Related]
17. G1 cyclin/cyclin-dependent kinase-coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression.
Calbó J; Parreño M; Sotillo E; Yong T; Mazo A; Garriga J; Grana X
J Biol Chem; 2002 Dec; 277(52):50263-74. PubMed ID: 12401786
[TBL] [Abstract][Full Text] [Related]
18. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
[TBL] [Abstract][Full Text] [Related]
19. A complex between E2F and the pRb-related protein p130 is specifically targeted by the simian virus 40 large T antigen during cell transformation.
Wolf DA; Hermeking H; Albert T; Herzinger T; Kind P; Eick D
Oncogene; 1995 Jun; 10(11):2067-78. PubMed ID: 7784051
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
